Exacerbation of chronic hepatitis B infection after delivery

Journal of Viral Hepatitis

Volumn 15, Issue 1, 2008, Pages 37-41

  Ter Borg, M J ^a   Leemans, W F ^a   De Man, R A ^a   Janssen, H L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chronic; Exacerbation; Flare; Hepatitis B; Lamivudine; Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; HEPATITIS B; HUMAN; LIVER FAILURE; PRIORITY JOURNAL; PUERPERIUM; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; VIRUS LOAD;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LIVER; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 36949012244     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00894.x     Document Type: Article

References (23)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine. 1995 13 (Suppl. 1 S47 S49.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997 24 : 1733 1745.
3. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995 13 : 29 60.
4. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006 7 (3 241 246.
5. Van Zonneveld M, Van Nunen AB, Niesters HG, De Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepatol 2003 10 (4 294 297.
6. Pas SD, Fries E, De Man RA, Osterhaus AD, Niesters HG. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 2000 38 (8 2897 2901.
7. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol 1999 37 (1 68 73.
8. Honkoop P, De Man RA, Niesters HG, Zondervan PE, Schalm SW. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology. 2000 32 (3 635 639.
9. Flink HJ, Sprengers D, Hansen BE et al. Flares in chronic hepatitis B patients induced by the host or the virus?. Relation to treatment response during Peg-interferon {alpha}-2b therapy Gut 2005 54 (11 1604 1609.
10. De Franchis R, Hadengue A, Lau G et al. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003 39 (Suppl. 1 S3 S25.
11. Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998 281 (5380 1191 1193.
12. Hunt JS, Vassmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997 158 (9 4122 4128.
13. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993 14 (7 353 356.
14. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000 287 (5452 498 501.
15. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004 5 (3 266 271.
16. Stoop JN, Van der Molen RG, Baan CC et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005 41 (4 771 778.
17. Yuan J, Lin J, Xu A et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006 13 (9 597 604.
18. Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006 21 : 3434 3437.
19. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004 6 : 910 912.
20. Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005 43 (5 771 775.
21. Liaw YF, Tai DI, Chu CM, Pao CC, Chen TJ. Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody-positive patients. Hepatology 1987 7 (1 20 23.
22. Dienstag JL, Schiff ER, Wright TL et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999 341 (17 1256 1263.
23. Soderstrom A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003 12 : 814 819.